Improvement in pulmonary function after IV antibiotic treatment in cystic fibrosis patients

G. Pisi, G. Grzincich, C. Spaggiari, G. Attanasi, R. Marvasi, A. Battistini (Parma, Italy)

Source: Annual Congress 2002 - Cystic fibrosis: new science, new epidemiology, new problems
Session: Cystic fibrosis: new science, new epidemiology, new problems
Session type: Thematic Poster Session
Number: 2125
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Pisi, G. Grzincich, C. Spaggiari, G. Attanasi, R. Marvasi, A. Battistini (Parma, Italy). Improvement in pulmonary function after IV antibiotic treatment in cystic fibrosis patients. Eur Respir J 2002; 20: Suppl. 38, 2125

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Antibiotic treatment of cystic fibrosis lung disease
Source: Eur Respir Monogr 2014; 64: 188-202
Year: 2014


Efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis with more preserved lung function
Source: Eur Respir J 2016; 48: 843-851
Year: 2016



PP309 – Effect of elexacaftor-tezacaftor-ivacaftor on pulmonary and endothelial function in a patient with advanced cystic fibrosis
Source: ERS Lung Science Conference 2021
Year: 2021

The lung clearance index correlates with markers of pulmonary deterioration in patients with cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013

The effectiveness of pulmonary rehabilitation in patients diagnosed with interstitial pulmonary fibrosis
Source: Virtual Congress 2020 – The multiple facets of pulmonary rehabilitation and chronic respiratory care
Year: 2020


Factors affecting the compliance to antifibrotic treatment in patients with interstitial pulmonary fibrosis
Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis
Year: 2019


Pulmonary hypertension in cystic fibrosis patients
Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools
Year: 2008


Effects of long-term azithromycin treatment in patients with non-cystic fibrosis stable bronchiectasis
Source: Annual Congress 2007 - Infectious lung and pleural diseases
Year: 2007


Lung clearance index improves with treatment of an exacerbation in cystic fibrosis
Source: Annual Congress 2007 - Cystic fibrosis lung disease: from diagnosis to end-stage
Year: 2007



Evaluation of functional capacity and pulmonary functions during acute pulmonary exacerbation in children with cystic fibrosis
Source: Virtual Congress 2020 – Exercise tolerance and functional status across respiratory diseases
Year: 2020


Cytomegalovirus-associated pulmonary exacerbation in patients with cystic fibrosis
Source: ERJ Open Res, 4 (1) 00111-2017; 10.1183/23120541.00111-2017
Year: 2018



Efficacy of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease
Source: Eur Respir J, 57 (2) 2003079; 10.1183/13993003.03079-2020
Year: 2021



Home intravenous antibiotic treatments in cystic fibrosis adult patients
Source: Eur Respir J 2002; 20: Suppl. 38, 158s
Year: 2002

Ataluren in nonsense mutation cystic fibrosis patients not receiving chronic inhaled tobramycin: Evaluation of exacerbations and lung function
Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring
Year: 2016


The oral AntibioticS approprIateness score (OASIS) – A novel scoring system to assess antibiotic route in pulmonary exacerbations of cystic fibrosis (CF)
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013


Lung clearance index in cystic fibrosis subjects treated for pulmonary exacerbations
Source: Eur Respir J 2015; 46: 1055-1064
Year: 2015



Long-term course of lung clearance index among patients with cystic fibrosis
Source: Virtual Congress 2020 – Respiratory physiology and sleep: new approaches to diagnosis and treatment
Year: 2020


Early detection of pulmonary exacerbations in children with cystic fibrosis by electronic home monitoring of symptoms and lung function
Source: International Congress 2016 – Cystic fibrosis: monitoring and management
Year: 2016


Changes in pulmonary function tests following antibiotics in infants with pulmonary exacerbation of cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: lung function and change of lung function in infants and children before and after treatment
Year: 2013


Clinical characteristics and pulmonary function in patients with pulmonary fibrosis assessed for lung transplant
Source: Annual Congress 2010 - Pre-operative evaluation and post-operative problems after lung transplantation
Year: 2010